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February 7, 2006:683–91ormal control subjects, both parameters are always within a very
arrow range in all myocardial segments. Yet, despite this varia-
ion, UTC analysis could easily identify widespread changes of
yocardial features in BMD patients compared with control
ubjects. In particular, cvIBS values in BMD patients were
arkedly different from the control group; no overlap was observed
etween cvIBS mean values in any of the sampled myocardial
egments. Conversely, significant changes in cIBS were detected
nly in the inferior, posterolateral base and inferolateral mid-
egments. These UTC findings in BMD patients as previously
escribed in DMD patients (3) support the hypothesis that
yocardial UTC analysis could reveal the early signs of a future
volution toward a segmental myocardial dysfunction.
Furthermore, we found that patients with a deletion encom-
assing exons 48 and/or 49 had lower values of cvIBS than patients
ith different or other deletions, possibly suggesting more subtle
hanges of myocardial physical properties in these patients, in
greement with a previous study suggesting a more frequent
ardiac involvement in BMD patients carrying deletions involving
xons 48 or 49 (2).
Probably, cvIBS is able to detect a different “cellular milieu”
nd, finally, early changes of myocardial properties in BMD
atients, even in the absence of functional myocardial dysfunction.
Our results show that a myocardial involvement is always
resent in BMD patients, independent of age, type of deletion,
mount of dystrophin in muscle, and severity of skeletal muscle
nvolvement, despite a normal left ventricular diastolic and systolic
unction.
This paper provides UTC values, in the widest number of
yocardial segments ever sampled, in BMD patients with a
unctionally normal heart.
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etters to the Editor
ink Between Arterial
nflammation and Circadian Rhythm:
he Oversight Aspect in the Year 2004
e read with great interest the recent report by Moreno P et al.
1) concerning inflammation as one of the primary pathophysio-
ogic processes in cardiovascular disease. However, we would like
o add two comments.
First, it has also been clearly documented that the occurrence of
oronary syndromes during the day are not uniform; rather, they
ccur with rhythmic variation. The existence of a circadian rhythm
n the acute coronary syndrome suggests that the problem might,
n some way, be associated with, or started by, physiological
hythms, with peak activity at certain parts of the day or night.
umerous studies have tried to establish the cause for this
ircadian rhythm and its clinical and therapeutic implications (2).
xperimental studies have shown that both immune cell number
nd immune functions may vary during the 24-h circadian period
3).
Second, the increase in mortality from cardiovascular events in
inter might be due to alterations in the biological clocks located
n the suprachiasmatic nuclei, whose rhythm is determined by
ay–night alternation, that is, by the light/darkness cycles. These
ycles regulate functions such as the secretion of cortisol (4), blood
ressure (5), vasomotor tone (6), tissue plasminogen activator (7),
nd pro-inflammatory cytokines (8,9).
Therefore, considering the potential association among inflam-
ation and circadian rhythm, the presence of a variability during
he 24 h of inflammatory and immunologic functions would
ermit, hypothetically, one to identify the light/dark times in
hich any peak of inflammatory activity could be associated with
greater incidence of cardiovascular events.
Alberto Dominguez-Rodriguez, MD, PhD
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EPLY
he specific commission of our review, titled “The Year in
therothrombosis,” was to highlight clinically relevant studies in
he field published within the last year (1). The letter from Dr.
omı´nguez-Rodriguez and colleagues highlights the importance
f the circadian rhythm in the presentation of acute coronary
vents, a concept established several years ago. The last citation of
heir letter quotes a study published in 2004, evaluating the
ight/dark cycle of cytokines and melatonin plasma levels in
atients with acute myocardial infarction (AMI) (2). This single,
bservational, case-control study suggested an association between
igh levels of interleukin-6 and low levels of melatonin during the
ark cycle in patients with AMI. The investigators should be
ongratulated for their effort. However, the study is not mecha-
istic, and does not prove causality. Furthermore, the clinical
ignificance of their findings still remains to be elucidated. As a
esult, in our judgment the study may not meet the criteria to be
ncluded as a clinically relevant publication in atherothrombosis in
he year 2004.
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iruses and Other Environmental Factors as
ossible Sources of Phenotypic Heterogeneity
n Familial Dilated Cardiomyopathy
n their interesting and recent state-of-the-art study, Burkett and
ershberger (1) stated that “familial dilated cardiomyopathy
DCM) demonstrates incomplete penetrance, variable expression,
nd significant locus and allelic heterogeneity, making clinical and
enetic diagnosis complex.” The statement clearly describes a key
roblem encountered during the genetic dissection of human
CM. This problem reaches beyond the fact that multiple genes
ay cause the DCM phenotype in humans and that further loci
hall be revealed in the future. Even within a single DCM family
r within a group of unrelated DCM patients harboring defects in
he same gene, there is often very large and currently unexplained
henotypic heterogeneity. There are at least two possible sources
or this heterogeneity.
First, unless representative healthy control populations are
creened for a given mutation one cannot be sure that this
utation is capable of causing the phenotype without additional
ofactors (modifier genes or environmental agents) being present.
n other genetic disorders the screening of large control popula-
ions has been the indispensable basis for the discovery of such
ofactors. For example, smoking was identified as an essential
nvironmental factor for the development of lung disease in
enetic 1-antitrypsin deficiency, initially assumed to cause the
isease per se on a pure genetic basis. For most mutations
ssociated with DCM we do not yet have frequency data repre-
entative of the general healthy population that can be compared
ith the rather small DCM patient cohorts from which the disease
ssociation is usually derived. The relative pathogenic contribution
f the gene defect per se as compared to hitherto unknown
ofactors is therefore uncertain.
Second, data on possible environmental agents are sparse in
olecular genetic studies of familial DCM. Regarding such
ofactors, we have recently detected cardiac viral infections in 165
67.4%) of 245 cases in a molecular virological survey based on
yocardial biopsies from a series of DCM patients (2), with a
road spectrum of virus species being involved. Cardiotropic
iruses thus emerged as prevalent environmental factors that may
ossibly cause or influence the course of DCM. The high fre-
uency of cardiotropic viruses detected in that DCM series makes
t highly likely that cardiac viruses are also encountered in familial
CM. They may explain part of the large phenotypic heteroge-
eity mentioned by Burkett and Hershberger (1), but will go
nnoticed unless cardiac biopsies are specifically investigated using
olecular virological methods. A synopsis of the current data
uggests that a comprehensive picture of the pathogenesis of
amilial DCM can only be obtained if both genetic and environ-
ental factors are analyzed. Studies of this type may lead to the
